DiaMedica Therapeutics Strengthens Balance Sheet with $12.2 Million Capital Raise While Advancing Preeclampsia Program
The company adds significant capital from a healthcare institution fund while making meaningful regulatory progress on novel therapeutic candidate.
After Extending Its Gains, The Greenback Softens
The US dollar is seeing this week’s gains pared against most of the G10 currencies today.
